Genetic and immunologic characterization of a novel serotype 4, 15 strain of Neisseria meningitidis

M C Bash1, F Lynn, N F Concepcion

  • 1Division of Bacterial Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA. bash@cber.fda.gov

Insights

Outer membrane proteins (OMPs) like porin are key for Neisseria meningitidis vaccines. This study identified specific porin variable regions (VRs) and found the VR1 epitope is a promising target for developing broadly protective vaccines.

Area of Science:

  • Microbiology
  • Vaccinology
  • Immunology

Background:

  • Porin proteins are crucial components of outer membrane protein (OMP) vaccines against Neisseria meningitidis.
  • Understanding the diversity of porin proteins is essential for developing effective vaccines.

Purpose of the Study:

  • To characterize the porB variable regions (VRs) of a novel Neisseria meningitidis serogroup B isolate (Ch501).
  • To investigate the immunogenicity and immune response to specific porin epitopes.
  • To assess the potential of porin epitopes in developing broadly protective group B meningococcal vaccines.

Main Methods:

  • PorB variable region (VR) typing was performed on the Ch501 isolate.
  • Rabbit immunization studies using outer membrane vesicles were conducted.
  • Bactericidal activity assays were used to evaluate serum-mediated killing.

Main Results:

  • The porB gene of the Ch501 isolate exhibited specific variable region types (VR1-4, VR2-15, VR3-15, VR4-15).
  • Immunization studies revealed immunodominance of individual class 3 PorB VR epitopes.
  • The predominant immune response was directed towards the VR1 epitope, which mediated bactericidal activity.

Conclusions:

  • The VR1 epitope of class 3 porin shows potential as a target for broadly protective Neisseria meningitidis vaccines.
  • Further studies on the molecular epidemiology of porB VRs and immune responses are warranted.
  • Targeting specific porin epitopes may enhance the efficacy of OMP vaccines.

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...